An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study

Clinical trial NCT06736509 · TERMINATED

Trial details

NCT number

NCT06736509

Sponsor

Axsome Therapeutics, Inc.

Status

TERMINATED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2024-11-21

Primary completion

2025-02-17

Enrollment

139

View on ClinicalTrials.gov